166 related articles for article (PubMed ID: 8790394)
21. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
[TBL] [Abstract][Full Text] [Related]
22. Sequence, genomic organization, and chromosome localization of the mouse TRADD gene.
Pan MG; Xiong J; Copeland NG; Gilbert DJ; Jenkins NA; Goeddel DV
J Inflamm; 1995-1996; 46(3):168-75. PubMed ID: 8844497
[TBL] [Abstract][Full Text] [Related]
23. NF-kappaB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27.
Yamamoto H; Kishimoto T; Minamoto S
J Immunol; 1998 Nov; 161(9):4753-9. PubMed ID: 9794406
[TBL] [Abstract][Full Text] [Related]
24. The structural basis for the recognition of diverse receptor sequences by TRAF2.
Ye H; Park YC; Kreishman M; Kieff E; Wu H
Mol Cell; 1999 Sep; 4(3):321-30. PubMed ID: 10518213
[TBL] [Abstract][Full Text] [Related]
25. Cloning and characterization of a cDNA for rat CD30 homolog and chromosomal assignment of the genomic gene.
Aizawa S; Satoh H; Horie R; Ito K; Choi SH; Takeuchi H; Watanabe T
Gene; 1996 Dec; 182(1-2):155-62. PubMed ID: 8982082
[TBL] [Abstract][Full Text] [Related]
26. The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation.
Brown SA; Richards CM; Hanscom HN; Feng SL; Winkles JA
Biochem J; 2003 Apr; 371(Pt 2):395-403. PubMed ID: 12529173
[TBL] [Abstract][Full Text] [Related]
27. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of WEHI-231 cells from anti-IgM-induced growth arrest.
Sutherland CL; Krebs DL; Gold MR
J Immunol; 1999 Apr; 162(8):4720-30. PubMed ID: 10202013
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells.
Mir SS; Richter BW; Duckett CS
Blood; 2000 Dec; 96(13):4307-12. PubMed ID: 11110706
[TBL] [Abstract][Full Text] [Related]
29. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.
Pullen SS; Labadia ME; Ingraham RH; McWhirter SM; Everdeen DS; Alber T; Crute JJ; Kehry MR
Biochemistry; 1999 Aug; 38(31):10168-77. PubMed ID: 10433725
[TBL] [Abstract][Full Text] [Related]
30. Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent.
Manning E; Pullen SS; Souza DJ; Kehry M; Noelle RJ
Eur J Immunol; 2002 Jan; 32(1):39-49. PubMed ID: 11754002
[TBL] [Abstract][Full Text] [Related]
31. Translocation of TRAF proteins regulates apoptotic threshold of cells.
Arch RH; Gedrich RW; Thompson CB
Biochem Biophys Res Commun; 2000 Jun; 272(3):936-45. PubMed ID: 10860854
[TBL] [Abstract][Full Text] [Related]
32. Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kappabeta transcription factor.
Gruss HJ; Ulrich D; Dower SK; Herrmann F; Brach MA
Blood; 1996 Mar; 87(6):2443-9. PubMed ID: 8630409
[TBL] [Abstract][Full Text] [Related]
33. Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40.
Tsukamoto N; Kobayashi N; Azuma S; Yamamoto T; Inoue J
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1234-9. PubMed ID: 9990007
[TBL] [Abstract][Full Text] [Related]
34. Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling.
Buchan SL; Al-Shamkhani A
PLoS One; 2012; 7(9):e45244. PubMed ID: 23028875
[TBL] [Abstract][Full Text] [Related]
35. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.
Pomerantz JL; Baltimore D
EMBO J; 1999 Dec; 18(23):6694-704. PubMed ID: 10581243
[TBL] [Abstract][Full Text] [Related]
36. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
[TBL] [Abstract][Full Text] [Related]
37. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.
Horie R; Watanabe T; Morishita Y; Ito K; Ishida T; Kanegae Y; Saito I; Higashihara M; Mori S; Kadin ME; Watanabe T
Oncogene; 2002 Apr; 21(16):2493-503. PubMed ID: 11971184
[TBL] [Abstract][Full Text] [Related]
38. Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75.
Declercq W; Denecker G; Fiers W; Vandenabeele P
J Immunol; 1998 Jul; 161(1):390-9. PubMed ID: 9647248
[TBL] [Abstract][Full Text] [Related]
39. CD40 signaling through a newly identified tumor necrosis factor receptor-associated factor 2 (TRAF2) binding site.
Lu LF; Cook WJ; Lin LL; Noelle RJ
J Biol Chem; 2003 Nov; 278(46):45414-8. PubMed ID: 12960157
[TBL] [Abstract][Full Text] [Related]
40. CD30 ligation induces nuclear factor-kappa B activation in human T cell lines.
McDonald PP; Cassatella MA; Bald A; Maggi E; Romagnani S; Gruss HJ; Pizzolo G
Eur J Immunol; 1995 Oct; 25(10):2870-6. PubMed ID: 7589085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
